Postprandial Control: Data highlights that sitagliptin significantly reduces 2-hour post-meal glucose spikes, which is a major driver of cardiovascular risk
Its front-and-center in a lot of employees lives. Access bonus Workspan Daily Plus+ content on this subject: Increasing Demand Poses Expensive Deliberations Among the nearly 300 employers surveyed by the IFEBP for a recent study, 34% are now covering GLP-1 drugs for both diabetes management and weight loss, up 8 percentage points from 12 months ago
Moreover, in a 4 T1 mouse model of breast cancer, researchers employed a combination of cryo-thermal therapy and all-trans-RA to address myeloid-derived suppressor cells (MDSCs)
Generic injectable semaglutide (Ozempic/Wegovy equivalent) is unlikely before 2031-2032 due to formulation patent barriers
Everyone living with psoriasis experiences a different combination of type, symptoms, activity, and severity